Celldex Therapeutics (CLDX)
19.92 +0.03 (+0.15%) 15:53 ET [NASDAQ]
19.90 x 95 19.93 x 1
Realtime by (Cboe BZX)
19.90 x 95 19.93 x 1
Realtime 19.89 unch (unch) 09:27 ET
for Wed, Mar 19th, 2025
Results
download Want to compare other data? Select FieldsSymbol | CLDX | AZN | AMGN | GILD | VRTX |
Company | Celldex Therapeutics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 19.79 | 76.98 | 317.51 | 109.69 | 512.01 |
High | 20.15 | 77.03 | 318.92 | 109.72 | 514.64 |
Low | 19.55 | 76.17 | 313.40 | 105.80 | 505.00 |
Last | 19.92 | 76.36 | 315.54 | 107.12 | 512.98 |
Change | +0.03 | -0.71 | -3.11 | -3.11 | +0.75 |
% Change | +0.15% | -0.92% | -0.98% | -2.82% | +0.15% |
Volume | 232,970 | 3,081,763 | 994,685 | 8,420,579 | 682,420 |
20-Day Average Volume | 726,013 | 6,094,898 | 3,026,270 | 9,737,042 | 1,333,081 |
Previous Close | 19.89 | 77.07 | 318.65 | 110.23 | 512.23 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 20.65 | 76.16 | 313.30 | 112.94 | 491.31 |
20-Day Raw Stochastic | 23.74% | 58.26% | 53.25% | 8.90% | 87.09% |
20-Day Relative Strength | 40.51% | 57.95% | 59.38% | 50.07% | 66.24% |
Weighted Alpha | -54.71 | +12.84 | +13.64 | +53.94 | +24.76 |
Today's Opinion | 100% Sell | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
Previous Opinion | 100% Sell | 56% Buy | 56% Buy | 88% Buy | 56% Buy |
Last Month's Opinion | 100% Sell | 8% Buy | 24% Sell | 100% Buy | 24% Sell |
Performance | |||||
5-Days | |||||
%Chg | -6.75% since 03/12/25 | +1.03% since 03/12/25 | +1.21% since 03/12/25 | -6.08% since 03/12/25 | +3.68% since 03/12/25 |
Low | 19.47 on 03/18/25 | 76.17 on 03/19/25 | 310.30 on 03/14/25 | 105.80 on 03/19/25 | 488.00 on 03/13/25 |
High | 21.55 on 03/13/25 | 77.76 on 03/17/25 | 319.31 on 03/18/25 | 115.46 on 03/13/25 | 519.68 on 03/14/25 |
1-Month | |||||
%Chg | -14.36% since 02/19/25 | +3.43% since 02/19/25 | +7.48% since 02/19/25 | -0.55% since 02/19/25 | +8.88% since 02/19/25 |
Low | 18.61 on 03/04/25 | 73.54 on 02/21/25 | 293.93 on 02/20/25 | 105.80 on 03/19/25 | 472.80 on 02/20/25 |
High | 23.37 on 02/21/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
3-Month | |||||
%Chg | -22.22% since 12/19/24 | +18.47% since 12/19/24 | +21.09% since 12/19/24 | +17.53% since 12/19/24 | +29.50% since 12/19/24 |
Low | 18.61 on 03/04/25 | 63.75 on 12/20/24 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 386.49 on 12/20/24 |
High | 29.05 on 01/08/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
6-Month | |||||
%Chg | -52.04% since 09/19/24 | -3.24% since 09/19/24 | -5.86% since 09/19/24 | +27.60% since 09/19/24 | +7.48% since 09/19/24 |
Low | 18.61 on 03/04/25 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
High | 47.00 on 09/25/24 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 1,320,378 | 239,006,560 | 171,180,384 | 137,274,496 | 131,535,536 |
Shares Outstanding, K | 66,384 | 3,101,162 | 537,205 | 1,245,346 | 256,790 |
Annual Sales | 7,020,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
Annual Net Income | -157,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
Last Quarter Sales | 1,180,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
Last Quarter Net Income | -47,090,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
60-Month Beta | 1.76 | 0.41 | 0.53 | 0.21 | 0.41 |
Per-Share Information | |||||
Most Recent Earnings | -0.71 on 02/27/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
Latest Earnings Date | 05/05/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 18.82 | 16.00 | 24.35 | 0.00 |